These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18334757)

  • 1. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology.
    Wang DS; Uchikado H; Bennett DA; Schneider JA; Mufson EJ; Wu J; Dickson DW
    J Alzheimers Dis; 2008 Feb; 13(1):53-66. PubMed ID: 18334757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains.
    Zhang J; Wang S; Huang W; Bennett DA; Dickson DW; Wang D; Wang R
    Mol Neurobiol; 2016 Oct; 53(8):5066-78. PubMed ID: 26386840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
    Wilhelmus MM; de Jager M; Bakker EN; Drukarch B
    J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking.
    Wilhelmus MMM; Jongenelen CA; Bol JGJM; Drukarch B
    Anal Biochem; 2020 Mar; 592():113578. PubMed ID: 31923381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue transglutaminase is not a biochemical marker for Alzheimer's disease.
    Wolf J; Jäger C; Lachmann I; Schönknecht P; Morawski M; Arendt T; Mothes T
    Neurobiol Aging; 2013 Nov; 34(11):2495-8. PubMed ID: 23747046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models.
    Wilhelmus MM; de Jager M; Smit AB; van der Loo RJ; Drukarch B
    Sci Rep; 2016 Feb; 6():20569. PubMed ID: 26837469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tissue transglutaminase promotes Aβ-induced apoptosis in SH-SY5Y cells.
    Zhang J; Ding YR; Wang R
    Acta Pharmacol Sin; 2016 Dec; 37(12):1534-1542. PubMed ID: 27665848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease.
    Citron BA; SantaCruz KS; Davies PJ; Festoff BW
    J Biol Chem; 2001 Feb; 276(5):3295-301. PubMed ID: 11013236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy.
    de Jager M; van der Wildt B; Schul E; Bol JG; van Duinen SG; Drukarch B; Wilhelmus MM
    Neurobiol Aging; 2013 Apr; 34(4):1159-69. PubMed ID: 23122413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
    Forman MS; Mufson EJ; Leurgans S; Pratico D; Joyce S; Leight S; Lee VM; Trojanowski JQ
    Neurology; 2007 Mar; 68(10):757-63. PubMed ID: 17339583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
    Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
    Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue transglutaminase: an enzyme with a split personality.
    Chen JS; Mehta K
    Int J Biochem Cell Biol; 1999 Aug; 31(8):817-36. PubMed ID: 10481269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
    Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
    Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of transglutaminase-catalyzed isopeptide bonds in paired helical filaments and neurofibrillary tangles from Alzheimer's disease.
    Balin BJ; Loewy AG; Appelt DM
    Methods Enzymol; 1999; 309():172-86. PubMed ID: 10507024
    [No Abstract]   [Full Text] [Related]  

  • 19. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.